BIO-key International, Inc. (BKYI) Key Metrics
BKYI valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $5.4M
- Enterprise value
- $3.0M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- 0.8
- Price / book
- 0.8
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- 0.50
BKYI key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsBKYI returns How much profit the business earns on the capital it uses.
BKYI financial health Debt, liquidity and how easily interest is covered.
BKYI efficiency & capital use Working capital cycle and where the cash goes.
BKYI valuation history
BKYI returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
BKYI debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
BKYI cash returned to shareholders
BKYI price vs earnings per share
BKYI key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $3.6M | — | — | — | — | — | — | — | — | — |
| Enterprise value | $1.6M | — | — | — | — | — | — | — | — | — |
| Price / sales | 0.6 | — | — | — | — | — | — | — | — | — |
| Price / book | 0.5 | — | — | — | — | — | — | — | — | — |
| EV / sales | 0.3 | — | — | — | — | — | — | — | — | — |
| Earnings yield | −127.9% | — | — | — | — | — | — | — | — | — |
| Free cash flow yield | −130.2% | — | — | — | — | — | — | — | — | — |
| Share price at fiscal year-end | $5.40 | $17.10 | $30.00 | $106.20 | $397.80 | $633.60 | $720.00 | $1,080.00 | $2,548.80 | $3,816.00 |
| Per share | ||||||||||
| Revenue per share | $9.17 | — | — | — | — | — | — | — | — | — |
| Earnings per share | −$6.91 | — | — | — | — | — | — | — | — | — |
| Operating cash flow per share | −$7.01 | — | — | — | — | — | — | — | — | — |
| Free cash flow per share | −$7.03 | — | — | — | — | — | — | — | — | — |
| Cash per share | $4.05 | — | — | — | — | — | — | — | — | — |
| Book value per share | $11.54 | — | — | — | — | — | — | — | — | — |
| Tangible book value per share | $10.29 | — | — | — | — | — | — | — | — | — |
| Capex per share | $0.02 | — | — | — | — | — | — | — | — | — |
| Debt per share | $1.06 | — | — | — | — | — | — | — | — | — |
| Shares outstanding | 665K | — | — | — | — | — | — | — | — | — |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | −80.2% | −177.9% | −267.8% | −113.9% | −28.2% | −107.2% | — | −56.7% | −29.3% | −24.9% |
| Return on invested capital (ROIC) | −62.4% | −105.1% | −204.4% | −111.7% | −66.8% | −234.9% | — | −45.9% | −24.2% | −23.0% |
| Return on assets (ROA) | −47.1% | −65.5% | −107.5% | −81.8% | −25.1% | −77.3% | −205.6% | −49.5% | −25.6% | −22.2% |
| Return on tangible assets | −45.7% | −57.2% | −274.1% | −124.3% | −33.4% | −49.1% | −643.1% | −146.0% | −53.7% | −63.9% |
| Free cash flow margin | −76.7% | −42.2% | −48.9% | −89.9% | −176.4% | −175.8% | −82.9% | −41.9% | −42.7% | −151.2% |
| Financial health | ||||||||||
| Total debt | $703,626 | $1.8M | $365,346 | $3.2M | $264,162 | $730,472 | $2.8M | $9,436 | $5,614 | $26,988 |
| Cash & short-term investments | $2.7M | $437,604 | $511,399 | $2.6M | $7.8M | $17.5M | $591,834 | $323,943 | $288,721 | $1.1M |
| Net debt | −$2.0M | $1.3M | −$146,053 | $604,942 | −$7.5M | −$16.8M | $2.2M | −$314,507 | −$283,107 | −$1.0M |
| Debt / equity | 0.09 | 0.47 | 0.34 | 0.61 | 0.02 | 0.04 | — | 0.00 | 0.00 | 0.00 |
| Debt / assets | 0.06 | 0.21 | 0.08 | 0.29 | 0.01 | 0.03 | 1.13 | 0.00 | 0.00 | 0.00 |
| Current ratio | 1.49 | 0.41 | 0.82 | 1.65 | 7.01 | 10.10 | 0.31 | 3.45 | 3.02 | 2.67 |
| Quick ratio | 1.37 | 0.33 | 0.68 | 0.83 | 4.54 | 9.92 | 0.21 | 2.63 | 2.61 | 2.42 |
| Interest coverage | -13.4 | -13.4 | -40.4 | -948.5 | -274.5 | -1.2 | -12.6 | — | — | — |
| Working capital | $1.5M | −$2.7M | −$591,232 | $3.5M | $12.0M | $17.1M | −$3.0M | $3.0M | $4.7M | $3.1M |
| Invested capital | $5.7M | $5.1M | $917,512 | $5.9M | $8.1M | $3.6M | −$60,527 | $10.2M | $13.5M | $14.4M |
| Tangible asset value | $6.8M | $2.7M | −$344,425 | $3.5M | $13.0M | $17.5M | −$2.5M | $3.5M | $5.6M | $4.7M |
| Net current asset value | $1.4M | −$3.0M | −$831,313 | $2.9M | $11.9M | $16.8M | −$3.4M | $3.0M | $4.7M | $3.1M |
| Graham net-net per share | $0.93 | — | — | — | — | — | — | — | — | — |
| Capital allocation | ||||||||||
| Dividends paid | — | — | — | — | — | — | — | — | $630,408 | $535,100 |
| Share buybacks (net) | — | — | $561,367 | $0 | — | $0 | $361,273 | $0 | $0 | $0 |
| Capex / revenue | 0.2% | 0.2% | 0.0% | 1.2% | 0.8% | 1.3% | 1.3% | 2.0% | 3.6% | 1.8% |
| Capex / depreciation | 0.03 | 0.03 | 0.00 | 0.15 | 0.08 | 0.08 | 0.03 | 0.05 | 0.14 | 0.85 |
| Stock-based compensation / revenue | 2.4% | 3.5% | 3.4% | 5.5% | 6.2% | 27.9% | 41.8% | 24.2% | 14.9% | 14.4% |
| R&D / revenue | 42.8% | 36.2% | 30.9% | 46.3% | 46.0% | 49.2% | 58.7% | 35.0% | 26.3% | 67.5% |
| SG&A / revenue | 103.1% | 103.0% | 109.2% | 137.3% | 117.9% | 206.2% | 222.1% | 131.9% | 90.1% | 149.2% |
| Efficiency | ||||||||||
| Days sales outstanding | 61.0 | 55.1 | 67.6 | 69.5 | 71.6 | 73.4 | 150.3 | 208.3 | 133.3 | 309.4 |
| Days of inventory on hand | 99.6 | 116.6 | 140.8 | 701.3 | 575.1 | 174.5 | 105.9 | 85.3 | 39.7 | 203.6 |
| Days payables outstanding | 176.2 | 302.1 | 70.0 | 114.9 | 73.3 | 267.1 | 103.9 | 43.0 | 27.2 | 406.5 |
| Cash conversion cycle (days) | -15.6 | -130.3 | 138.5 | 655.9 | 573.3 | -19.3 | 152.3 | 250.6 | 145.8 | 106.5 |
| Receivables turnover | 5.99 | 6.62 | 5.40 | 5.25 | 5.10 | 4.97 | 2.43 | 1.75 | 2.74 | 1.18 |
| Payables turnover | 2.07 | 1.21 | 5.22 | 3.18 | 4.98 | 1.37 | 3.51 | 8.49 | 13.42 | 0.90 |
| Inventory turnover | 3.67 | 3.13 | 2.59 | 0.52 | 0.63 | 2.09 | 3.45 | 4.28 | 9.18 | 1.79 |
| Asset turnover | 0.63 | 1.06 | 0.98 | 0.48 | 0.25 | 0.23 | 0.32 | 0.29 | 0.38 | 0.16 |
| Average receivables | $1.0M | $1.0M | $1.4M | $1.3M | $1.0M | $570,222 | $933,828 | $2.3M | $2.3M | $2.5M |
| Average payables | $662,772 | $1.1M | $1.2M | $768,026 | $335,965 | $581,726 | $700,282 | $490,250 | $483,036 | $812,698 |
| Average inventory | $374,593 | $412,024 | $2.4M | $4.7M | $2.6M | $380,033 | $713,974 | $972,838 | $706,138 | $407,036 |
| Intangibles / total assets | 7.6% | 12.7% | 31.2% | 15.5% | 14.7% | 12.6% | 9.1% | 59.8% | 50.5% | 62.1% |
Computed from BKYI's annual financial statements (latest annual report filed June 12, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
BKYI valuation and financial ratios
BIO-key International earned a return on equity of −80.2% and a return on invested capital of −62.4% in fiscal 2025. It ended the year with $0.7 million of debt and $2.7 million in cash and short-term investments, a net cash position of $2.0 million.
See the BKYI income statement, the BKYI chart for price history, or the BKYI stock overview for the latest quote and news.
BKYI key metrics FAQ
What is BIO-key International's return on equity?
BIO-key International's return on equity (ROE) was −80.2% in fiscal 2025: net income of -$4.6 million on average shareholders' equity of $5.7 million.
What is BIO-key International's ROIC?
BIO-key International's return on invested capital was −62.4% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does BIO-key International have?
BIO-key International had total debt of $0.7 million at the end of fiscal 2025, a debt-to-equity ratio of 0.09 and more cash than debt.
What is BIO-key International's free cash flow yield?
BIO-key International generated -$4.7 million of free cash flow in fiscal 2025, a free cash flow yield of −130.2% on its market value at year-end ($3.6 million).
What is BIO-key International's current ratio?
BIO-key International's current ratio was 1.49 at the end of fiscal 2025: current assets were 1.49 times current liabilities.